Deep Vein Thrombosis

Clinical Trial Finder

Many patients with deep vein thrombosis are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Thrombin Generation in Crohn's Disease

Conditions:   Crohn Disease;   Blood Clot;   Thrombosis
Intervention:  
Sponsors:   University of Sao Paulo General Hospital;   Fundação de Amparo à Pesquisa do Estado de São Paulo
Not yet recruiting - verified May 2015

Comparison of Thromboembolic Events Between Enoxa® and Lovenox® in Patients Undergoing Digestive Cancer

Condition:   Enoxaparin Digestive System Neoplasms
Intervention:   Drug: Enoxaparin 4000 UI
Sponsor:   Les Laboratoires des Médicaments Stériles
Not yet recruiting - verified May 2015

Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib

Conditions:   Advanced Renal Cell Carcinoma;   Kidney Cancer
Interventions:   Drug: Sunitinib;   Drug: Isoquercetin;   Drug: Placebo
Sponsor:   Consorzio Oncotech
Not yet recruiting - verified May 2015

Early Post-Marketing Study of ELIQUIS (Apixaban) in Mexico

Conditions:   Deep Vein Thrombosis;   Pulmonary Embolism
Intervention:   Drug: Apixaban
Sponsor:   Bristol-Myers Squibb
Not yet recruiting - verified May 2015

Safety and Efficacy Study of Apixaban to Prevent Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With PEG Asparaginase

Conditions:   Lymphoma;   Acute Lymphoblastic Leukemia
Interventions:   Drug: Apixaban;   Other: No systemic anticoagulant prophylaxis
Sponsor:   Bristol-Myers Squibb
Recruiting - verified April 2015

Multimodal DVT Protocol in Tourniquet-less Total Knee Arthroplasty

Condition:   Deep Vein Thrombosis
Intervention:   Device: extended compression
Sponsor:   TriHealth Inc.
Completed - verified May 2015

Sequential Expansion of Comparative Effectiveness of Anticoagulants

Condition:   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified May 2015

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Conditions:   Pulmonary Embolism;   Thromboembolism;   Thrombosis;   Venous Thrombosis;   Venous Thromboembolism
Interventions:   Drug: BAY 59-7939;   Drug: BAY 59-7939;   Drug: ASA
Sponsor:   Bayer
Recruiting - verified May 2015

Belgian Real Life Non-interventional Study (NIS) in Patients Treated With Xarelto Following an Acute Deep Vein Thrombosis (DVT)

Condition:   Venous Thrombosis
Intervention:   Drug: Rivaroxaban (Xarelto, BAY59-7939)
Sponsor:   Bayer
Completed - verified May 2015

Venous Thromboembolic Prophylaxis After Major Trauma: A Trial of Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin

Conditions:   Venous Thromboembolic Disease;   Deep Vein Thrombosis;   Pulmonary Embolism
Interventions:   Drug: 5000 Units unfractionated Heparin Q 8 hours;   Drug: 30mg enoxaparin Q12 hours
Sponsor:   Scripps Health
Active, not recruiting - verified September 2014

A Cohort Study With 100 Subjects Having a Primary Total Knee Replacement, Taking Pradax Post Discharge for Ten Days

Condition:   Thromboembolism
Intervention:   Drug: Pradax
Sponsors:   Nova Scotia Health Authority;   Ross K Leighton MD FRCSC
Withdrawn - verified May 2009

Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure

Conditions:   Venous Thrombosis;   Pulmonary Embolism
Intervention:   Drug: Tinzaparin
Sponsors:   St. Joseph's Healthcare Hamilton;   Heart and Stroke Foundation of Ontario;   LEO Pharma
Recruiting - verified May 2015

Get CardioSmart

You're Invited